nitrogen-containing heterocycles.3 However, an intermo-
lecular cycloaddition of ylides with dipolarophiles is
known to be synthetically unsuitable in CMCRs because
of their low selectivity and the competitive side reactions
such as epoxidation, dioxolane formation. Further-
more, the cycloaddition of carbonyl ylides with imines
to produce oxazolidines has received limited attention
because of their low dipolarophilicity. Recently, an elegant
approach has been reported by Somfai et al. for the
cycloaddition of a carbonyl ylide generated from ethyl
diazoacetate and aromatic aldehyde with aldimine.4 How-
ever, this method suffers from low conversion and moderate
diastereoselectivity with respect to substrate. Competitive
dioxolane formation reduces the efficiency of this method
(Scheme 1).
ylides from carbenoids. Therefore, the cyclic ketimines
could be used to produce the spirooxindolyl-1,3-oxazoli-
dines and spirooxindolyl-1,3-pyrrolidines. Such spiroox-
indoles, oxazolidines, and pyrrolidines have emerged as
attractive synthetic targets because of their prevalence in
biologically active natural products and drugs7 (Figure 1).
Herein, we report a novel approach for the construction
of spirooxindolyl-1,3-oxazolidines and spirooxindolyl-1,3-
pyrrolines via the coupling of diazomalonate and ketimine
with aldehyde or with dimethyl acetylenedicarboxylate,
respectively.
Accordingly, the three-component coupling (3CC) of
dimethyl diazomalonate with benzaldehyde and N-methyl-
isatin-3-arylimine in the presence of 5 mol % of Rh2(OAc)4
afforded the spirooxindolyl-1,3-oxazolidine 4a in 86%
yield (entry a, Table 1). The 1H NMR analysis of a crude
sample indicates the exclusive formation of cycloadduct 4a
as a single diastereomer. The product was purified by flash
column chromatography on silica gel and characterized by
spectroscopic analysis.
Scheme 1
The spectral data evidently confirm the proposed struc-
ture for 4a. The relative stereochemistry of spirooxindolyl-
1,3-oxazolidine 4q was determined on the basis of X-ray
crystallography (see the Supporting Information).
Like carbonyl ylide, the generation of azomethine ylide
from N-benzylideneaniline and diazo compound has also
been reported to facilitate cycloaddition with diplorophiles
to produce the pyrrolidines and pyrroles.5 But N-benzyli-
deneaniline fails to undergo cycloaddition with carbonyl
ylide (Scheme 1). Therefore, there is still a need to find a
suitable imine that can trap the carbonyl ylide effectively
without the formation of any epoxide and dioxolane and
also to generate the azomethine ylide.
As a part of our research program on diazocarbonyl
compounds, we recently reported the synthesis of spiroox-
indolyl lactams and oxazinones through the trapping of
acylketeneswithisatin-based cyclicketimines.6 Weinitially
envisaged that the cyclic ketimines derived from isatin
could be interesting if they act as good dipolarophiles to
trap the carbonyl ylides and also to generate azomethine
Figure 1. Biologically active spirooxindolyl oxazole and pyrro-
line derivatives.
Encouraged by the initial results, we further examined
the reactivity of ketimines with various carbonyl ylides
generated from diazomalonate and electron-rich as well as
electron-deficient aryl aldehydes (Table 1). In order to
investigate the competitive side reactions such as epoxida-
tion and 1,3-dioxolane formation, we performed the 3CC
reaction with electron-deficient aryl aldehydes which
usually serve as dipolarophiles in the formation of dioxo-
lanes. Surprisingly, no such formation of dioxolane was
observed with p-nitrobenzaldehyde under the present re-
action conditions. Inspired by this observation, we extended
its effectiveness to the preparation of spirooxazolidine with
a highly electron-deficient substrate, i.e., 2,4-dinitrobenzal-
dehyde. Remarkably, the corresponding oxazolidine was
obtained in good yield under the present reaction conditions
without the formation of dioxolane (entries d and r, Table 1)
although 2,4-dinitrobenzaldehyde is known to act as an
excellent dipolarophile in carbonyl ylide cycloadditions.
(4) (a) Torssell, S.; Kienle, M.; Somfai, P. Angew. Chem., Int. Ed.
2005, 44, 3096. (b) Torssell, S.; Somfai, P. Adv. Synth. Catal. 2006, 348,
24214.
(5) (a) Li, G. Y.; Chen, J.; Yu, W. Y.; Hong, W.; Che, C. M. Org. Lett.
2003, 5, 2153. (b) Galliford, C. V.; Scheidt, K. A. J. Org. Chem. 2007, 72,
1811.
(6) Reddy, B. V. S.; Karthik, G.; Rajasekaran, T.; Antony, A.;
Sridhar, B. Tetrahedron Lett. 2012, 53, 2396.
(7) (a) Badillo, J. J.; Hanhan, N. V.; Franz, A. K. Curr. Opin. Drug
Discovery Dev. 2010, 13, 758. (b) Galliford, C. V.; Scheidt, K. A. Angew.
Chem., Int. Ed. 2007, 46, 8748. (c) Yeung, B. K. S.; Zou, B.; Rottmann,
M.; Lakshminarayana, S. B.; Ang, S. H.; Leong, S. Y.; Tan, J.; Wong, J.;
Keller-Maerki, S.; Fischli, C.; Goh, A.; Schmitt, E. K.; Krastel,
P.; Francotte, E.; Kuhen, K.; Plouffe, D.; Henson, K.; Wagner, T.;
Winzeler, E. A.; Petersen, F.; Brun, R.; Dartois, V.; Diagana, T. T.;
Keller, T. H. J. Med. Chem. 2010, 53, 5155. (d) Vintonyak, V.; Warburg,
K.; Kruse, H.; Grimme, S.; Hubel, K.; Rauh, D.; Waldmann, H. Angew.
Chem., Int. Ed. 2010, 49, 5902. (e) Jiang, X.; Cao, Y.; Wang, Y.; Liu, L.;
Shen, F.; Wang, R. J. Am. Chem. Soc. 2010, 132, 15328. (f) Bhaskar, G.;
Arun, Y.; Balachandran, C.; Saikumar, C.; Perumal, P. T. Eur. J. Med.
Chem. 2012, 51, 79.
Org. Lett., Vol. 15, No. 7, 2013
1513